Search

everythinglearnresearchcommunity

for

Search:↓

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.

The new delivery method for finasteride using nanoparticles may improve hair growth without skin issues.

Oral contraceptives are generally recommended for healthy young girls, but specific types may vary based on individual health conditions and barrier methods are less popular among adolescents.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Allopregnanolone may help prevent nicotine withdrawal symptoms.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

High levels of certain fats in rapeseed oil can reduce the skin's ability to produce prostaglandin E2 and cause hair loss and skin issues in rats.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Oral contraceptives and antiandrogens are the best treatments for hirsutism.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Lignans from Urtica triangularis may help treat benign prostatic hyperplasia (BPH).

Nanocarrier-based treatments show promise for better hair growth in androgenetic alopecia but need more research.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.